Cytek Biosciences, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cytek Biosciences, Inc. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Cytek Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$4.39M, a 525% decline year-over-year.
  • Cytek Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$5.85M, a 125% decline year-over-year.
  • Cytek Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$12.1M, a 589% decline from 2022.
  • Cytek Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $2.48M, a 17.9% decline from 2021.
  • Cytek Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $3.03M, a 84.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$12.1M -$14.6M -589% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $2.48M -$543K -17.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $3.03M -$16.4M -84.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-13
2020 $19.4M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.